Ginkgo Bioworks Holdings, Inc (DNA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jason Kelly
Employees:
640
27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA, 02210
(877) 442-5362

Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.

Data derived from most recent annual or quarterly report
Market Cap 2.876 Billion Shares Outstanding1.094 Billion Avg 30-day Volume 34.513 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.48
Price to Revenue10.4048 Debt to Equity0.0329 EBITDA-2.812 Billion
Price to Book Value2.5122 Operating Margin-818.0873999999999 Enterprise Value2.556 Billion
Current Ratio11.841 EPS Growth0 Quick Ratio11.495
1 Yr BETA 2.5583 52-week High/Low 15.86 / 2.09 Profit Margin-801.2913
Operating Cash Flow Growth0.0 Altman Z-Score-0.7249 Free Cash Flow to Firm 0
Earnings Report2022-11-14
View SEC Filings from DNA instead.

View recent insider trading info

Ginkgo Bioworks Holdings, Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DNA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3/A: filed on 2022-03-28 by BELLDEGRUN ARIE
  • 4: filed on 2022-03-04 by VIKING GLOBAL INVESTORS LP
  • 4: filed on 2022-01-26 by DMYTRUK MARK E.
  • 4: filed on 2022-01-26 by FALLON MARIE E.
  • 4: filed on 2021-12-08 by KELLY JASON R
  • 4: filed on 2021-12-08 by CANTON BARRY
  • 4: filed on 2021-12-08 by SHETTY RESHMA P.
  • 4: filed on 2021-11-23 by KEWALRAMANI RESHMA
  • 4: filed on 2022-03-14 by DEKKERS MARIJN E
  • 4: filed on 2022-03-14 by HENRY CHRISTIAN O

    • Events (8k)

  • 8-K: filed on 2022-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-25:
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DEKKERS MARIJN E

    • Director
    		 7,902,030 2022-03-11 1

    HENRY CHRISTIAN O

    • Director
    		 1,305,943 2022-03-11 1

    SANKAR SHYAM

    • Director
    		 1,260,953 2022-03-11 1

    FALLON MARIE E. SEE REMARKS

    • Officer
    		 248,894 2022-03-11 2

    DMYTRUK MARK E. SEE REMARKS

    • Officer
    		 5,823,514 2022-03-10 2

    VIKING GLOBAL INVESTORS LP

    VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

    VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

    VIKING GLOBAL OPPORTUNITIES PARENT GP LLC

    VIKING GLOBAL OPPORTUNITIES GP LLC

    HALVORSEN OLE ANDREAS

    OTT DAVID C.

    SHABET ROSE SHARON

    		339,055,144 2022-03-02 1

    KELLY JASON R SEE REMARKS

    • Officer
    • Director
    		 82,581,106 2021-12-06 1

    SHETTY RESHMA P. SEE REMARKS

    • Officer
    • Director
    • 10% Owner
    		 153,210,648 2021-12-06 1

    CANTON BARRY

    • 10% Owner
    		 153,410,648 2021-12-06 1

    KEWALRAMANI RESHMA

    • Director
    		 9,818 2021-11-19 1

    BELLDEGRUN ARIE

    • Director
    		 518,741 2021-09-16 1

    BOYER HERBERT W PH D

    • Director
    		 11,000 2007-04-20 0

    SANDERS CHARLES A

    • Director
    		 11,000 2007-04-20 0

    REED DEBRA L

    • Director
    		 11,000 2007-04-20 0

    ANDREATTA ROBERT E CONTROLLER AND

    • Officer
    		 1,263 2007-04-19 0

    SCHELLER RICHARD H EXECUTIVE VICE PRESIDENT

    • Officer
    		 101,042 2007-04-16 0

    EBERSMAN DAVID A EVP & CHIEF FINANCIAL OFFICER

    • Officer
    		 114,497 2007-02-15 0

    CLARK IAN T EVP-COMMERCIAL OPERATIONS

    • Officer
    		 7,474 2007-01-19 0

    WHITING JOHN M VICE PRESIDENT, CONTROLLER

    • Officer
    		 7,845 2007-01-18 0

    JUELSGAARD STEPHEN G EXECUTIVE VICE PRESIDENT,

    • Officer
    		 4,811 2007-01-12 0

    LEVINSON ARTHUR D CHAIRMAN & CEO

    • Officer
    • Director
    		 8,612 2007-01-12 0

    DESMOND HELLMANN SUSAN D PRESIDENT,

    • Officer
    		 967 2007-01-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-08 15:15:04 UTC -1.7585 4.0785 15000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-08 14:45:03 UTC -1.7585 4.0785 20000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-08 14:15:03 UTC -1.7585 4.0785 20000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-08 13:45:03 UTC -1.5905 3.9105 20000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-08 13:15:03 UTC -1.5905 3.9105 20000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-08 12:45:03 UTC -1.5905 3.9105 6000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 22:15:05 UTC -1.5905 3.9105 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 21:45:05 UTC -1.2772 3.5972 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 21:15:04 UTC -1.2772 3.5972 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 20:45:03 UTC -1.2652 3.5852 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 20:15:05 UTC -1.2652 3.5852 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 19:45:04 UTC -1.2652 3.5852 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 19:15:04 UTC -1.2652 3.5852 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 18:45:04 UTC -1.0155 3.3355 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 18:15:05 UTC -1.0155 3.3355 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 17:45:04 UTC -1.0155 3.3355 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 17:15:05 UTC -1.0155 3.3355 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 16:45:04 UTC -0.7706 3.0906 8000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 16:15:04 UTC -0.7706 3.0906 10000
    GINKGO BIOWORKS HOLDINGS INC DNA 2022-09-07 15:45:04 UTC -0.7706 3.0906 10000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund DNA -127400.0 shares, $-303212.0 2022-06-30 N-PORT
    CRM Mutual Fund Trust- CRM LONG/SHORT OPPORTUNITIES DNA -405454.0 shares, $-964980.52 2022-06-30 N-PORT

    Elevate your investments